LSE - Delayed Quote EUR

Clariane SE (0OPS.L)

14.63 +0.09 (+0.64%)
As of July 21 at 6:19 PM GMT+1. Market Open.
Loading Chart for 0OPS.L
DELL
  • Previous Close 14.53
  • Open 14.70
  • Bid --
  • Ask --
  • Day's Range 14.46 - 14.94
  • 52 Week Range 5.41 - 14.94
  • Volume 12,553
  • Avg. Volume 79,390
  • Market Cap (intraday) 12.001M
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 0.20
  • EPS (TTM) 0.73
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

www.clariane.com

--

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0OPS.L

Clariane Delivers Main Financing Milestones

Clariane Delivers Main Financing Milestones

Performance Overview: 0OPS.L

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0OPS.L
506.08%
MSCI WORLD
5.01%

1-Year Return

0OPS.L
109.96%
MSCI WORLD
0.00%

3-Year Return

0OPS.L
52.96%
MSCI WORLD
12.96%

5-Year Return

0OPS.L
56.63%
MSCI WORLD
53.05%

Compare To: 0OPS.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0OPS.L

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.25%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.05B

  • Net Income Avi to Common (ttm)

    -49.5M

  • Diluted EPS (ttm)

    0.73

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights: 0OPS.L